aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Vyne Therapeutics is a biopharmaceutical company dedicated to developing innovative therapies for dermatologic conditions. The company focuses on challenging traditional assumptions to create better solutions for patients. Vyne's approach involves questioning conventional methods and exploring novel approaches to address complex therapeutic challenges in dermatology and beyond.
Vyne Therapeutics maintains an active pipeline of products aimed at developing innovative treatments for patients. The company's commitment to innovation and problem-solving in the dermatology field positions it as a forward-thinking player in the biopharmaceutical industry. Vyne Therapeutics is publicly traded, allowing investors to participate in its mission to advance dermatological care.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Therapeutics, Dermatology
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
United States
When was Vyne Therapeutics founded?
Vyne Therapeutics was founded in 2003.
Where is Vyne Therapeutics’s headquarters located?
Vyne Therapeutics’s headquarters is located in Bridgewater Township, NJ, US.
When was Vyne Therapeutics’s last funding round?
Vyne Therapeutics’s most recent funding round was for $88M (USD) in October 2023.
How many employees does Vyne Therapeutics have?
Vyne Therapeutics has 61 employees as of Feb 6, 2024.
How much has Vyne Therapeutics raised to-date?
As of July 05, 2023, Vyne Therapeutics has raised a total of $297.8M (USD) since Oct 30, 2023.
Add Comparison
Total Raised to Date
$297.8M
USD
Last Update Oct 30, 2023
Last Deal Details
$88M
USD
Oct 30, 2023
Post Ipo Equity
Total Employees Over Time
61
As of Feb 2024
Vyne Therapeutics Address
520 u.s. Highway 22
Suite 204
Bridgewater Township,
New Jersey
08807
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts